Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09IWI
|
|||
| Former ID |
DNC010573
|
|||
| Drug Name |
N-(Propylamide-acetophenone)-1-deoxynojirimycin
|
|||
| Synonyms |
CHEMBL589341; N-(Propylamide-acetophenone)-1-deoxynojirimycin
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H30N2O7
|
|||
| Canonical SMILES |
C#CCOC1=CC=C(C=C1)C(=O)CCC(=O)NCCCN2CC(C(C(C2CO)O)O)O
|
|||
| InChI |
1S/C22H30N2O7/c1-2-12-31-16-6-4-15(5-7-16)18(26)8-9-20(28)23-10-3-11-24-13-19(27)22(30)21(29)17(24)14-25/h1,4-7,17,19,21-22,25,27,29-30H,3,8-14H2,(H,23,28)/t17-,19+,21-,22-/m1/s1
|
|||
| InChIKey |
AAWCULUAQOJFJX-HGIWEUDGSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glucosylceramidase (GBA) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Other glycan degradation | |||
| Sphingolipid metabolism | ||||
| Metabolic pathways | ||||
| Lysosome | ||||
| Pathwhiz Pathway | Sphingolipid Metabolism | |||
| Reactome | Glycosphingolipid metabolism | |||
| WikiPathways | Sphingolipid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Nanomolar affinity, iminosugar-based chemical probes for specific labeling of lysosomal glucocerebrosidase. Bioorg Med Chem. 2010 Jan 1;18(1):267-73. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.